Aytu Biopharma (AYTU) Shares Outstanding (2014 - 2026)
Aytu Biopharma (AYTU) posted quarterly Shares Outstanding (Entity) of $10.7 million for Q1 2026, up 73.95% year-over-year from $6.2 million in Q1 2025, and down 20.64% quarter-over-quarter from $13.5 million in Q4 2025.
Aytu Biopharma (AYTU) Shares Outstanding (2014 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Shares Outstanding (Entity) for 13 consecutive years, with $10.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 73.95% year-over-year to $10.7 million; the TTM figure through Mar 2026 stood at $10.7 million (up 73.95% YoY), while the FY2025 annual figure was $14.4 million, up 140.68% from the prior year.
- Shares Outstanding (Entity) eased to $10.7 million in Q1 2026 per AYTU's latest filing, from $13.5 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $14.4 million in Q2 2025 and bottomed at $1.5 million in Q2 2022.
- Historically, Shares Outstanding (Entity) has averaged $6.2 million across 5 years, with a median of $5.6 million in 2024.
- On a YoY basis, Shares Outstanding (Entity) climbed as much as 140.68% in 2025 and fell as far as 10.82% in 2025.
- Aytu Biopharma's Shares Outstanding (Entity) stood at $3.4 million in 2022, then jumped by 64.56% to $5.6 million in 2023, then rose by 10.82% to $6.2 million in 2024, then surged by 119.22% to $13.5 million in 2025, then declined by 20.64% to $10.7 million in 2026.
- Business Quant data shows AYTU's Shares Outstanding (Entity) at $10.7 million in Q1 2026, $13.5 million in Q4 2025, and $9.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 832.44 Mn |
| 10 | Aytu Biopharma | 24.49 Mn | -2.22 Mn | 7.60 Mn | 10.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.51 Mn |
| Dec 31, 2025 | 13.52 Mn |
| Sep 30, 2025 | 9.44 Mn |
| Jun 30, 2025 | 14.38 Mn |
| Mar 31, 2025 | 6.13 Mn |
| Dec 31, 2024 | 6.13 Mn |
| Sep 30, 2024 | 6.07 Mn |
| Jun 30, 2024 | 6.25 Mn |
| Mar 31, 2024 | 5.53 Mn |
| Dec 31, 2023 | 5.52 Mn |
| Sep 30, 2023 | 5.48 Mn |
| Jun 30, 2023 | 3.34 Mn |
| Mar 31, 2023 | 3.73 Mn |
| Dec 31, 2022 | 3.11 Mn |
| Sep 30, 2022 | 2.52 Mn |
| Jun 30, 2022 | 1.47 Mn |
| Mar 31, 2022 | 1.48 Mn |
| Dec 31, 2021 | 1.32 Mn |
| Sep 30, 2021 | 1.28 Mn |
| Jun 30, 2021 | 837,334.00 |